{
    "Trade/Device Name(s)": [
        "VIDAS\u00ae C. difficile GDH",
        "VIDAS C. difficile GDH Assay"
    ],
    "Submitter Information": "bioM\u00e9rieux SA",
    "510(k) Number": "K132010",
    "Predicate Device Reference 510(k) Number(s)": [
        "K053572"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "MCB"
    ],
    "Summary Letter Date": "September 16, 2013",
    "Summary Letter Received Date": "September 17, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.2660"
    ],
    "Regulation Name(s)": [
        "Microorganism Differentiation and Identification Device"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Clostridium difficile glutamate dehydrogenase"
    ],
    "Specimen Type(s)": [
        "Fecal"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "VIDAS family instruments"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme linked fluorescent assay (ELFA)"
    ],
    "Methodologies": [
        "Enzyme immunoassay sandwich method",
        "Fluorescent detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for VIDAS C. difficile GDH enzyme linked fluorescent assay for qualitative screening of C. difficile antigen in fecal specimens",
    "Indications for Use Summary": "Qualitative screening for C. difficile antigen (glutamate dehydrogenase) in fecal specimens from persons suspected of C. difficile infection, used as an aid in diagnosis in conjunction with other toxin tests and patient history",
    "fda_folder": "Microbiology"
}